Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis?
Co-prescription of anti-inflammatory prophylaxis with colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), or corticosteroids when initiating urate-lowering therapy (ULT) for gout is recommended in clinical guidelines to prevent ULT-induced flares and optimise adherence to ULT. Colchicine pro...
Saved in:
Main Authors: | Edward Roddy, James A. Prior, Christian D. Mallen |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2024-11-01
|
Series: | Exploration of Musculoskeletal Diseases |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100776/100776.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout
by: M. N. Chikina
Published: (2019-01-01) -
Colchicine for acute arthritis attacks prevention in patients with gout during urate-lowering therapy (results of a pilot study)
by: M. S. Eliseev, et al.
Published: (2021-08-01) -
Impact of urate-lowering therapy on quality of life indicators in patients with gout
by: M. N. Chikina, et al.
Published: (2021-06-01) -
Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
by: J. Chen, et al.
Published: (2021-04-01) -
Is Urate-lowering therapy a prevention of first gout episode?
by: Michał Szczepański, et al.
Published: (2025-07-01)